CCS Medical, Inc. Sustainability Profile
CCS Medical, Inc., headquartered in the United States, is a leading provider in the healthcare industry, specialising in the delivery of medical supplies and services. Founded in 1994, the company has established a strong presence across various operational regions, focusing on home healthcare solutions for patients with chronic conditions. CCS Medical offers a diverse range of core products, including diabetes management supplies, wound care products, and urological supplies, all designed to enhance patient care and improve quality of life. What sets CCS Medical apart is its commitment to personalised service and innovative delivery methods, ensuring that patients receive the right products at the right time. With a reputation for reliability and excellence, CCS Medical has achieved significant milestones in the healthcare sector, positioning itself as a trusted partner for both patients and healthcare providers.
DitchCarbon Score
How does CCS Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Retail Trade Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
CCS Medical, Inc.'s score of 23 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
CCS Medical, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor does it report specific reduction targets or initiatives. The company is classified as a current subsidiary and inherits its climate commitments and performance metrics from its parent organisation, but no specific data has been provided from that source. As a result, CCS Medical, Inc. has not disclosed any absolute emissions figures in kg CO2e, nor has it outlined any significant climate pledges or targets, such as those from the Science Based Targets initiative (SBTi). The absence of this information suggests that the company may still be in the early stages of developing its climate strategy or reporting framework. In the context of the industry, many companies are increasingly focusing on reducing their carbon footprints and committing to sustainability goals. However, without specific data or commitments from CCS Medical, Inc., it is challenging to assess their current standing in relation to these industry trends.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 1,336,900,000 | 0,000,000,000 | 0,000,000,000 |
| Scope 2 | 14,330,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
How Carbon Intensive is CCS Medical, Inc.'s Industry?
How Carbon Intensive is CCS Medical, Inc.'s Location?
CCS Medical, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
CCS Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
